$35M QVAR Inhaler Settlement Resolves Teva Pharmaceuticals Antitrust Lawsuit
May 6, 2026 A $35M QVAR settlement ends a class action lawsuit that alleges Teva illegally sought to block competition for its inhaler products.
May 6, 2026 A $35M QVAR settlement ends a class action lawsuit that alleges Teva illegally sought to block competition for its inhaler products.
March 4, 2026 An antitrust class action lawsuit alleges that UFC has monopolized the MMA market, forcing fans to pay inflated prices to stream live events.
September 5, 2024 A class action alleges Apple has deliberately chosen not to adopt safety measures that would help prevent the storage and distribution of child sexual abuse material on iCloud.
December 21, 2023 A class action alleges Humana’s use of an AI model to predict insureds’ healthcare needs has caused elderly patients to be wrongfully denied post-acute care coverage.
June 22, 2022 A proposed class action alleges the New York Times has engaged in an unlawful automatic renewal scheme for subscriptions to its website in North Carolina.
January 12, 2022 A class action alleges The Athletic has automatically renewed North Carolina customers’ monthly subscriptions without providing requisite disclosures and receiving authorization to do so.